Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-EN Version v1-EN
Language English English
Date Updated 2020-02-05 2020-01-16
Drug Identification Number 02241356 02241356
Brand name IFEX (IFOSFAMIDE) 3 G/VIAL IFEX (IFOSFAMIDE) 3 G/VIAL
Common or Proper name IFEX (IFOSFAMIDE) 3 G/VIAL IFEX (IFOSFAMIDE) 3 G/VIAL
Company Name BAXTER CORPORATION BAXTER CORPORATION
Ingredients IFOSFAMIDE IFOSFAMIDE
Strength(s) 3G 3G
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 3g vial 3g vial
ATC code L01AA L01AA
ATC description ALKYLATINGAGENTS ALKYLATINGAGENTS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2020-01-16 2020-01-16
Actual start date 2020-01-16 2020-01-16
Estimated end date 2020-02-04 2020-02-10
Actual end date 2020-02-04
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments Customers can choose the alternate format of IFEX 1G if it fits their clinical need. Customers can choose the alternate format of IFEX 1G if it fits their clinical need.
Health Canada comments